Cortical atrophy in experimental autoimmune encephalomyelitis: In vivo imaging

NeuroImage

Volumn 60, Issue 1, 2012, Pages 95-104

  MacKenzie Graham, Allan ^a   Rinek, Gilda A ^a   Avedisian, Andrea ^a   Gold, Stefan M ^b   Frew, Andrew J ^a   Aguilar, Cynthia ^c   Lin, David R ^a   Umeda, Elizabeth ^b   Voskuhl, Rhonda R ^b   Alger, Jeffry R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

^c INDIANA UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SYNAPSIN I;

ALLERGIC ENCEPHALOMYELITIS; ANATOMICAL CONCEPTS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CELL COUNT; CEREBELLUM; CEREBELLUM ATROPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GRAY MATTER; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERMETHOD COMPARISON; MOUSE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SENSITIVITY ANALYSIS; TREND STUDY; VOLUMETRY;

ANIMALS; ATROPHY; CEREBELLUM; CEREBRAL CORTEX; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MICE;

EID: 84855992573     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.11.099     Document Type: Article

References (52)

1. Ahrens E.T., Laidlaw D.H., Readhead C., Brosnan C.F., Fraser S.E., Jacobs R.E. MR microscopy of transgenic mice that spontaneously acquire experimental allergic encephalomyelitis. Magn. Reson. Med. 1998, 40:119-132.
2. Amato M.P., Bartolozzi M.L., Zipoli V., Portaccio E., Mortilla M., Guidi L., Siracusa G., Sorbi S., Federico A., De Stefano N. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004, 63:89-93.
3. Amato M.P., Portaccio E., Goretti B., Zipoli V., Battaglini M., Bartolozzi M.L., Stromillo M.L., Guidi L., Siracusa G., Sorbi S., Federico A., De Stefano N. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Arch. Neurol. 2007, 64:1157-1161.
4. Amato M.P., Portaccio E., Stromillo M.L., Goretti B., Zipoli V., Siracusa G., Battaglini M., Giorgio A., Bartolozzi M.L., Guidi L., Sorbi S., Federico A., De Stefano N. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 2008, 71:632-638.
5. Badea A., Ali-Sharief A.A., Johnson G.A. Morphometric analysis of the C57BL/6J mouse brain. Neuroimage 2007, 37:683-693.
6. Bermel R.A., Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol. 2006, 5:158-170.
7. Bock N.A., Kovacevic N., Lipina T.V., Roder J.C., Ackerman S.L., Henkelman R.M. In vivo magnetic resonance imaging and semiautomated image analysis extend the brain phenotype for cdf/cdf mice. J. Neurosci. 2006, 26:4455-4459.
8. Borg J., Chereul E. Differential MRI patterns of brain atrophy in double or single transgenic mice for APP and/or SOD. J. Neurosci. Res. 2008, 86:3275-3284.
9. Budde M.D., Kim J.H., Liang H.F., Russell J.H., Cross A.H., Song S.K. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed. 2008, 21:589-597.
10. Calabrese M., Mattisi I., Rinaldi F., Favaretto A., Atzori M., Bernardi V., Barachino L., Romualdi C., Rinaldi L., Perini P., Gallo P. Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2010, 81:401-404.
11. De Stefano N., Giorgio A., Battaglini M., Rovaris M., Sormani M.P., Barkhof F., Korteweg T., Enzinger C., Fazekas F., Calabrese M., Dinacci D., Tedeschi G., Gass A., Montalban X., Rovira A., Thompson A., Comi G., Miller D.H., Filippi M. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 2010, 74:1868-1876.
12. De Stefano N., Matthews P.M., Filippi M., Agosta F., De Luca M., Bartolozzi M.L., Guidi L., Ghezzi A., Montanari E., Cifelli A., Federico A., Smith S.M. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003, 60:1157-1162.
13. Delatour B., Guegan M., Volk A., Dhenain M. In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol. Aging 2006, 27:835-847.
14. Edwards S.G., Gong Q.Y., Liu C., Zvartau M.E., Jaspan T., Roberts N., Blumhardt L.D. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 1999, 122(Pt 2):291-301.
15. Fisher E., Rudick R.A., Simon J.H., Cutter G., Baier M., Lee J.C., Miller D., Weinstock-Guttman B., Mass M.K., Dougherty D.S., Simonian N.A. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002, 59:1412-1420.
16. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Academic Press, New York. 3rd ed.
17. Gallyas F. Silver staining of myelin by means of physical development. Neurol. Res. 1979, 1:203-209.
18. Geurts J.J., Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008, 7:841-851.
19. Jacobs R.E., Ahrens E.T., Dickinson M.E., Laidlaw D. Towards a microMRI atlas of mouse development. Comput. Med. Imaging Graph. 1999, 23:15-24.
20. Kovacevic N., Henderson J.T., Chan E., Lifshitz N., Bishop J., Evans A.C., Henkelman R.M., Chen X.J. A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. Cereb. Cortex 2005, 15:639-645.
21. Lau J.C., Lerch J.P., Sled J.G., Henkelman R.M., Evans A.C., Bedell B.J. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage 2008, 42:19-27.
22. Levy H., Assaf Y., Frenkel D. Characterization of brain lesions in a mouse model of progressive multiple sclerosis 2010, Exp Neurol.
23. Liu C., Edwards S., Gong Q., Roberts N., Blumhardt L.D. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1999, 66:323-330.
24. Liu H.B., Loo K.K., Palaszynski K., Ashouri J., Lubahn D.B., Voskuhl R.R. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J. Immunol. 2003, 171:6936-6940.
25. Ma Y., Hof P.R., Grant S.C., Blackband S.J., Bennett R., Slatest L., McGuigan M.D., Benveniste H. A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience 2005, 135:1203-1215.
26. MacKenzie-Graham A., Lee E.F., Dinov I.D., Bota M., Shattuck D.W., Ruffins S., Yuan H., Konstantinidis F., Pitiot A., Ding Y., Hu G., Jacobs R.E., Toga A.W. A multimodal, multidimensional atlas of the C57BL/6J mouse brain. J. Anat. 2004, 204:93-102.
27. MacKenzie-Graham A., Tinsley M.R., Shah K.P., Aguilar C., Strickland L.V., Boline J., Martin M., Morales L., Shattuck D.W., Jacobs R.E., Voskuhl R.R., Toga A.W. Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis. Neuroimage 2006, 32:1016-1023.
28. MacKenzie-Graham A., Tiwari-Woodruff S.K., Sharma G., Aguilar C., Vo K.T., Strickland L.V., Morales L., Fubara B., Martin M., Jacobs R.E., Johnson G.A., Toga A.W., Voskuhl R.R. Purkinje cell loss in experimental autoimmune encephalomyelitis. Neuroimage 2009, 48:637-651.
29. Mangiardi M., Crawford D.K., Xia X., Du S., Simon-Freeman R., Voskuhl R.R., Tiwari-Woodruff S.K. An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis 2010, Brain Pathol.
30. Miller D.H., Barkhof F., Frank J.A., Parker G.J., Thompson A.J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002, 125:1676-1695.
31. Morrissey S.P., Stodal H., Zettl U., Simonis C., Jung S., Kiefer R., Lassmann H., Hartung H.P., Haase A., Toyka K.V. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 1996, 119(Pt 1):239-248.
32. Peterson L.K., Fujinami R.S. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 2007, 184:37-44.
33. Pettinelli C.B., McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J. Immunol. 1981, 127:1420-1423.
34. Pirko I., Johnson A.J., Chen Y., Lindquist D.M., Lohrey A.K., Ying J., Dunn R.S. Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis 2010, Neuroimage.
35. Pirko I., Nolan T.K., Holland S.K., Johnson A.J. Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model. Radiology 2008, 246:790-795.
36. Pomeroy I.M., Jordan E.K., Frank J.A., Matthews P.M., Esiri M.M. Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci. Lett. 2008, 437:121-124.
37. Pomeroy I.M., Jordan E.K., Frank J.A., Matthews P.M., Esiri M.M. Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Mult. Scler. 2010, 16:537-548.
38. Rex D.E., Ma J.Q., Toga A.W. The LONI Pipeline Processing Environment. Neuroimage 2003, 19:1033-1048.
39. Rudick R.A., Fisher E., Lee J.C., Simon J., Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999, 53:1698-1704.
40. Shattuck D.W., Leahy R.M. Automated graph-based analysis and correction of cortical volume topology. IEEE Trans. Med. Imaging 2001, 20:1167-1177.
41. Siffrin V., Vogt J., Radbruch H., Nitsch R., Zipp F. Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends Neurosci. 2010, 33:202-210.
42. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
43. Suen W.E., Bergman C.M., Hjelmstrom P., Ruddle N.H. A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 1997, 186:1233-1240.
44. Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 1999, 12:295-302.
45. Wegner C., Esiri M.M., Chance S.A., Palace J., Matthews P.M. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006, 67:960-967.
46. Woods R.P., Grafton S.T., Holmes C.J., Cherry S.R., Mazziotta J.C. Automated image registration: I. General methods and intrasubject, intramodality validation. J. Comput. Assist. Tomogr. 1998, V22:139-152.
47. Woods R.P., Grafton S.T., Watson J.D., Sicotte N.L., Mazziotta J.C. Automated image registration: II. Intersubject validation of linear and nonlinear models. J. Comput. Assist. Tomogr. 1998, 22:153-165.
48. Wuerfel J., Tysiak E., Prozorovski T., Smyth M., Mueller S., Schnorr J., Taupitz M., Zipp F. Mouse model mimics multiple sclerosis in the clinico-radiological paradox. Eur. J. Neurosci. 2007, 26:190-198.
49. Zhang J., Peng Q., Li Q., Jahanshad N., Hou Z., Jiang M., Masuda N., Langbehn D.R., Miller M.I., Mori S., Ross C.A., Duan W. Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images. Neuroimage 2010, 49:2340-2351.
50. Ziehn M.O., Avedisian A.A., Tiwari-Woodruff S., Voskuhl R.R. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab. Invest. 2010, 90:774-786.
51. Zivadinov R., Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. J. Neuroimaging 2004, 14:27S-35S.
52. Zivadinov R., Bakshi R. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front. Biosci. 2004, 9:647-664.